test

BRIANNE SHERGILL

@Exome Asset Management Llc

Latest period2024 - Q3ReportedManaged Assets$293.574MTotal holdings59
Assets growth rate161.38%Assets growth rate (2-Q avg)78.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Exome Asset Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 59 positions.

Assets under management

The assets under management (AUM) of Exome Asset Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 293.574M in assets, with a quarterly growth rate of 161.38% and a 2-quarter average growth rate of 78.78%. The portfolio is managed by BRIANNE SHERGILL, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CNTACentessa Pharmaceuticals Plc
Recent Activity
Increased 0.52%
1.51%
$4.418M
276,304 shares@ $15.99 avg price
STOKStoke Therapeutics Inc
Recent Activity
New Position
1.48%
$4.341M
353,200 shares@ $12.29 avg price
AMGNAmgen Inc
Recent Activity
Increased 13.56%
1.48%
$4.318M
13,400 shares@ $322.21 avg price
GHGuardant Health Inc
Recent Activity
Increased 127.35%
1.41%
$4.12M
179,600 shares@ $22.94 avg price
NUVLNuvalent Inc
Recent Activity
New Position
1.4%
$4.081M
39,890 shares@ $102.31 avg price
RVNCRevance Therapeutics Inc
Recent Activity
New Position
1.23%
$3.608M
695,200 shares@ $5.19 avg price
KURAKura Oncology Inc
Recent Activity
Increased 37.1%
1.21%
$3.529M
180,610 shares@ $19.55 avg price
RZLTRezolute Inc
Recent Activity
Increased 149.34%
1.17%
$3.415M
704,112 shares@ $4.86 avg price
PLRXPliant Therapeutics Inc
Recent Activity
Increased 141.3%
1.15%
$3.354M
299,200 shares@ $11.21 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
New Position
1.09%
$3.197M
119,800 shares@ $26.69 avg price